Ginkgo biloba extract for treating epilepsy and application of ginkgo biloba extract for treating epilepsy

The invention provides a ginkgo biloba extract for treating epilepsy. Medicinal components of the ginkgo biloba extract include, by weight, 10%-12% of total gingko terpene lactones, 40%-44% of total flavonoids and 45%-50% of procyanidins, wherein the sum of weight percentages of the total gingko ter...

Full description

Saved in:
Bibliographic Details
Main Authors FANG LING, HUANG HAIBO, QIAO HONGXIANG, CHEN YAN, WU JIAN, WANG SHENGFENG, WU HUALING, SHAN WEIGUANG, WANG RUWEI
Format Patent
LanguageEnglish
Published 03.02.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides a ginkgo biloba extract for treating epilepsy. Medicinal components of the ginkgo biloba extract include, by weight, 10%-12% of total gingko terpene lactones, 40%-44% of total flavonoids and 45%-50% of procyanidins, wherein the sum of weight percentages of the total gingko terpene lactones, the total flavonoids and the procyanidins is larger than 95%, the weight percentage of total flavonol glycosides is 24%-26%, a ratio of weight percentages of the procyanidins to the total flavonoids is 1.05-1.25, and a ratio of weight percentages of the procyanidins to the total gingko terpene lactones is 4.0-4.4. The ginkgo biloba extract can be used for preparing medicines for treating sustained epilepsy, abnormal epileptic discharge in rat brains after epilepsy and learning and memory impairment caused by epilepsy.
Bibliography:Application Number: CN20151468962